blood pressure changes, headache, insomnia, depression Show MAO-B inhibitors have many potential adverse effects, including dizziness, insomnia, hallucinations, ataxia, agitation, depression, paresthesia, somnolence, headache, dyskinesia, nausea, diarrhea, hypotension or hypertension, chest pain, weight loss, dermatologic reactions, rhinitis, and pharyngitis. Scheduled maintenance: Thursday, December 8 from 5PM to 6PM PST
Home Subjects Expert solutions Create Log in Sign up Upgrade to remove ads Only ₩37,125/year
Terms in this set (10)A patient with Parkinson's disease who has been positively responding to carbidopa-levodopa (Sinemet) asks the nurse, "Why have I suddenly developed a relapse of my symptoms." Which explanation by the nurse is appropriate? "This is called the "on-off phenomenon." Your health care provider can change your medication regimen to help manage this effect." When teaching a patient about carbidopa-levodopa (Sinemet), what information should the nurse include about this medication? Carbidopa decreases levodopa's conversion in the periphery, increasing the levodopa available to cross the blood-brain barrier. Which antiparkinson drug causes an increase in the levels of dopaminergic stimulation in the central nervous system (CNS) and therefore allows a decreased dose of other medications? Selegiline (Eldepryl) What is the goal of pharmacologic therapy in treating Parkinson's disease? To balance cholinergic and dopaminergic activity in the brain The patient asks the nurse to explain the difference between carbidopa-levodopa (Sinemet) and ropinirole (Requip). How will the nurse respond? "Ropinirole is a dopamine agonist that has fewer adverse effects than carbidopa-levodopa." The nurse is caring for a patient with Parkinson's disease who has been taking entacapone (Comtan) for the past week to treat an on-off phenomenon. The patient expresses concern over brown-orange urine. What information will the nurse provide to the patient? This is a normal adverse effect of entacapone (Comtan) and is not harmful. A patient who has been taking antiparkinson medications for years begins to have increased symptoms on a constant basis. In documenting these symptoms, what term will the nurse use? Wearing-off phenomenon The nurse is providing care for a patient with a diagnosis of Parkinson's disease who has preexisting liver failure. What class of medications, if prescribed, would the nurse question? Catechol ortho-methyltransferase (COMT) inhibitors A patient with Parkinson's disease discusses with the nurse experiencing insomnia recently. The patient asks the nurse, "Can I take my old prescription of benzodiazepine that is prescribed to treat my insomnia?" What does the nurse know about the use of benzodiazepines in patients taking levodopa (Larodopa)? Use of benzodiazepines decreases the therapeutic effect of the levodopa and may result in an increase in the symptoms of Parkinson's disease. A patient is prescribed selegiline (Eldepryl), an MAO-B inhibitor, as adjunctive therapy in treatment of Parkinson's disease. What potential adverse effects should the nurse include in education for this patient? (Select all that apply.) Insomnia, headache, depression, blood pressure changes Students also viewedPharmacology Chapter 16: NCLEX Questions11 terms angela_ryals Chapter 1611 terms hopebg Pharmacology Chapter 17: NCLEX Questions9 terms angela_ryals HESI Case Study - Pain29 terms adkinsgc14 Sets found in the same folderPharm Chapter 14 NCLEX8 terms laura_n_greg Chapter 14 - Antiepileptic drugs16 terms laura_n_greg Chapter 15-Antiparkinsonian Drugs25 terms laura_n_greg Chapter 16-Psychotherapeutic Drugs52 terms laura_n_greg Other sets by this creatorPreparing Injections from a Vial5 terms laura_n_greg Assessing Wounds5 terms laura_n_greg Administering IV Medications by Piggyback5 terms laura_n_greg 1450 exam 3 review, Economics & Health Care Organi…32 terms laura_n_greg Verified questions
chemistry Write equilibrium constant expressions for these heterogeneous equilibria. $\mathrm{FeO}(\mathrm{s})+\mathrm{CO}(\mathrm{g}) \rightleftharpoons \mathrm{Fe}(\mathrm{s})+\mathrm{CO}_{2}(\mathrm{g})$ Verified answer
biology Which of the following is a nonrenewable resource? A wind$\hspace{2.7cm}$ C coal B fresh water$\hspace{2cm}$ D topsoil Verified answer
biology Which is when two alleles are observed in an individual? A incomplete dominance, B recessive, C codominance, D multiple dominance. Verified answer
earth science **Describe** how chemical and organic sedimentary rocks form, and give two examples of each. Verified answer Recommended textbook solutions Clinical Reasoning Cases in Nursing7th EditionJulie S Snyder, Mariann M Harding 2,512 solutions
Pharmacology and the Nursing Process7th EditionJulie S Snyder, Linda Lilley, Shelly Collins 388 solutions
Law and Ethics for Health Professions9th EditionCarlene Harrison, Karen Judson 836 solutions
Mathematics for Health Sciences1st EditionJoel Helms 1,674 solutions Other Quizlet setsPharmacy technician : final test (quiz)70 terms kymmi23 ISDS 351 FINAL STUDY GUIDE50 terms HectorAguilar562 Chapter 1540 terms OralTheSmurf CPT Study Guide; Section 3: Basic and Applied Scie…147 terms madisonaharvey What is the goal of pharmacologic therapy in treating Parkinsons disease?However, medications for Parkinson disease are usually effective in controlling the symptoms of the disease. Either levodopa or a dopamine agonist can be used initially for patients who require treatment for symptoms of Parkinson disease. One goal of therapy is finding the lowest effective dose of medication.
Which is the action of the pharmacotherapy used to treat Parkinson's disease?Dopaminergic drugs designed to replace the action of dopamine in the deplete striatum form the mainstay of PD treatment at present. This may be achieved through drugs that are metabolized to dopamine, that activate the dopamine receptor, or that prevent the breakdown of endogenous dopamine (4–6).
What is the first line pharmacotherapy for Parkinson's disease?For patients moderately affected by Parkinson's disease the first-line treatment is levodopa with a peripheral dopa decarboxylase inhibitor. A dopamine agonist may be added to minimise the dose of levodopa. Anticholinergic drugs may help patients with tremor.
What is Parkinson disease in pharmacology?Parkinson's disease (PD) is a gradually progressive neurodegenerative condition. The etiology and pathogenesis remain incompletely understood.
|
What is the goal of pharmacologic therapy in treating Parkinsons disease Quizlet
zusammenhängende Posts
Urheberrechte © © 2024 nguoilontuoi Inc.
